Saving the world, one steak at a time
Using our proprietary scaffold technology and decades of experience in tissue engineering, we are developing first-of-their-kind structured cuts of meat and steak.
Real meat people love
Ethically and sustainably sourced while reducing harm to our planet… and we do it without harming a single animal.
Decades of experience and track record of innovation in tissue engineering with both stem cells and scaffolds.
Mr. Bocking has been working in the capital markets for over 18 years. He has held various CEO and directorship roles. Mr. Bocking has been particularly focused on financing and structuring companies.
CTO and Co-Founder
Maghsoud has over 35 years of diverse and progressive management experience in the development, scale-up, and commercialization of products in the pharmaceutical and food industries. A biochemical engineer, he has a sound grasp of the science and technology required for successful commercialization of cultivated meats.
Dr. Mohit Bhatia
CSO and Co-Founder
Dr. Mohit Bhatia received his Ph.D. in biochemistry from New York University and completed his post-doctoral training at the Rockefeller University in New York as well as Harvard Medical School in Boston, MA. He worked with Celgene Corporation for over 20 years and holds several patents for placental biomaterials. Dr. Bhatia has published several papers and presented at leading conferences around the world for tissue-based therapies.
Dr. Yong Mao
Chemistry & Chem Biology
Dr. Yong Mao is an associate research professor in the Department of Chemistry and Chemical Biology at Rutgers University. She received her Ph.D. in molecular biology and biochemistry from Rutgers University. Then, started her research career at Princeton University focusing on the cell-extracellular matrix (ECM). Dr. Mao expanded her expertise in ECM as a senior scientist at LifeCell Corporation. She joined Rutgers University as research faculty in 2013, leading biological studies of ECM-polymer biomaterials and collaborations with industry on multiple translational research projects. She has over forty peer-reviewed scientific publications and is an inventor for four US patents. Dr. Mao brings her expertise to this project to develop textured scaffolds using decellularized tissue ECM and sustainable cell sources from both primary and stem cells.
Dr. Joseph Freeman
Dr. Joseph W. Freeman is a Professor in the Department of Biomedical Engineering at Rutgers University. After earning his B.S.E. in Chemical Engineering from Princeton University and his PhD in Biomedical Engineering from Rutgers University, Dr. Freeman became a faculty member of Rutgers University where he has continued his work. He specializes in research projects in muscle health and muscle tissue engineering and has over seventy publications in peer-reviewed journals. Dr. Freeman earned the Outstanding Engineering Faculty Award in 2020, is on the editorial board of several engineering journals, and is a fellow of the American Institute for Medical and Biological Engineering (AIMBE).
After starting his career at Goldman Sachs in London and on Wall Street, Nilesh transitioned to hedge fund investments. He has experience in the capital markets and a keen interest in risk assessment. Fluent in four languages, he graduated first in his class with a Master of Engineering from the University of Birmingham and McGill University. He earned his MBA at the University of Alberta in 2015, and he received his Chartered Financial Analyst (CFA) designation in 2017.